Please login to the form below

Not currently logged in
Email:
Password:

RedHill Biopharma

This page shows the latest RedHill Biopharma news and features for those working in and with pharma, biotech and healthcare.

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

RedHill Biopharma has announced that its experimental sphingosine kinase-2 (SK2) opaganib demonstrated potent inhibition of SARS-CoV-2 in an in vitro clinical test. ... benefit COVID-19 patients by inhibiting the key drivers of disease progression -

Latest news

  • RedHill Biopharma advances phase 2/3 COVID-19 programme RedHill Biopharma advances phase 2/3 COVID-19 programme

    Submits clinical trial applications in Mexico and Brazil. Israeli biopharmaceutical company RedHill Biopharma has announced that it has accelerated its COVID-19 programme with the submission of new clinical trial applications ... Last month, RedHill

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics